GSK plc

GSK · NYSE · Healthcare / Drug Manufacturers - General

50.45USD-0.19 (-0.38%)

Price History

Full chart

Market Stats

Previous Close50.64

Open50.25

Day Range50.13 – 50.80

52-Week Range44.63 – 60.11

Volume2.78M

Market Cap100.88B

P/E (TTM)17.54

Forward P/E9.85

EPS2.87

Dividend Yield3.61%

Beta0.28

50-Day Avg49.27

200-Day Avg52.38

About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - General
CEOMr. Luke Victor Miels
Employees66.84K
Headquarters79 New Oxford Street, London, United Kingdom, WC1A 1DG, USA
Websitehttps://www.gsk.com

Leadership

Ms. Julie Belita Brown A.C.A.CFO & Executive Director · b. 1962
Dr. Jesse L. Goodman M.D., M.P.H.Scientific & Medical Expert · b. 1951
Mr. Luke Victor MielsCEO & Director · b. 1974
Ms. Shobie RamakrishnanChief Digital & Technology Officer · b. 1971
Mr. Tony WoodChief Scientific Officer and Head of R&D
Mr. Jeff McLaughlinVP of Investor Relations & Interim Head of Investor Relations
Mr. James FordSenior VP and Group General Counsel of Legal & Compliance
Mr. David Simon Redfern BSc (Hons), CAPresident of Corporate Development · b. 1966
Ms. Roanne ParryChief People Officer · b. 1974
Mr. Philip C. ThomsonPresident of Global Affairs

Financials

Income Statement

Currency: GBP	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.74B	2.06B	2.57B	3.18B	3.40B	4.10B	4.93B	5.66B	6.48B	10.49B	8.34B	7.98B	7.98B	8.49B	18.08B	20.53B	21.21B	21.41B	19.98B	21.66B	23.22B	22.74B	24.35B	28.37B	28.39B	27.39B	26.43B	26.50B	23.01B	23.92B	27.89B	30.19B	30.82B	33.75B	24.35B	24.70B	29.32B	30.33B	31.38B	32.67B
Growth (%)	-	+18.27%	+24.82%	+23.70%	+6.86%	+20.58%	+20.36%	+14.73%	+14.57%	+61.88%	-20.49%	-4.33%	+0.04%	+6.35%	+112.94%	+13.58%	+3.30%	+0.95%	-6.71%	+8.40%	+7.21%	-2.06%	+7.10%	+16.49%	+0.08%	-3.54%	-3.49%	+0.28%	-13.20%	+3.99%	+16.58%	+8.24%	+2.10%	+9.52%	-27.85%	+1.40%	+18.74%	+3.42%	+3.46%	+4.11%
Cost of Revenue	-	-	-	-	-	-	-	-	904.11M	-	-	-	1.54B	4.33B	3.96B	4.44B	4.61B	4.54B	4.36B	4.76B	5.01B	5.21B	6.42B	7.38B	7.90B	7.65B	7.92B	8.59B	7.32B	8.85B	9.29B	10.34B	10.24B	11.86B	7.93B	8.16B	9.55B	8.56B	9.05B	9.02B
Gross Profit	1.74B	2.06B	2.57B	3.18B	3.40B	4.10B	4.93B	5.66B	5.58B	10.49B	8.34B	7.98B	6.44B	4.16B	14.12B	16.09B	16.60B	16.88B	15.62B	16.89B	18.21B	17.53B	17.94B	20.99B	20.49B	19.74B	18.51B	17.92B	15.68B	15.07B	18.60B	19.84B	20.58B	21.89B	16.43B	16.53B	19.77B	21.76B	22.33B	23.65B
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	86.05%	100.00%	100.00%	100.00%	80.65%	48.95%	78.09%	78.38%	78.27%	78.81%	78.18%	78.00%	78.43%	77.08%	73.66%	73.98%	72.18%	72.07%	70.02%	67.61%	68.17%	62.99%	66.69%	65.74%	66.77%	64.85%	67.44%	66.95%	67.42%	71.76%	71.16%	72.40%
Operating Expense	984.00M	1.21B	1.54B	1.95B	2.04B	2.81B	3.40B	3.84B	4.12B	8.11B	5.21B	5.16B	3.75B	1.53B	9.39B	9.99B	11.05B	10.49B	10.36B	10.03B	11.02B	9.59B	10.80B	12.56B	16.71B	11.93B	11.21B	10.89B	12.09B	4.75B	16.00B	15.76B	15.10B	14.93B	10.45B	12.18B	13.34B	15.02B	18.31B	15.72B
Operating Income	757.00M	853.00M	1.03B	1.23B	1.36B	1.29B	1.52B	1.82B	1.45B	2.38B	3.13B	2.82B	2.68B	2.63B	4.73B	6.10B	5.55B	6.38B	5.26B	6.86B	7.19B	7.94B	7.14B	8.43B	3.78B	7.81B	7.30B	7.03B	3.60B	10.32B	2.60B	4.09B	5.48B	6.96B	5.98B	4.36B	6.43B	6.75B	4.02B	7.93B
Operating Margin	43.48%	41.43%	40.16%	38.57%	39.98%	31.42%	30.93%	32.13%	22.43%	22.71%	37.55%	35.36%	33.61%	30.92%	26.16%	29.72%	26.17%	29.81%	26.33%	31.70%	30.95%	34.91%	29.32%	29.70%	13.32%	28.51%	27.62%	26.52%	15.64%	43.15%	9.32%	13.54%	17.79%	20.62%	24.55%	17.64%	21.94%	22.24%	12.82%	24.28%
EBITDA	812.00M	926.00M	1.13B	1.35B	1.51B	1.68B	1.96B	2.16B	1.78B	3.26B	3.65B	3.29B	3.23B	3.21B	7.11B	6.92B	6.54B	7.24B	6.61B	1.27B	8.76B	9.22B	8.73B	10.24B	5.62B	9.88B	8.80B	8.80B	5.16B	12.89B	4.43B	6.18B	7.35B	9.43B	8.07B	6.49B	8.60B	9.08B	6.67B	10.40B
EBITDA Margin	46.64%	44.97%	43.77%	42.40%	44.42%	41.04%	39.68%	38.21%	27.53%	31.05%	43.76%	41.18%	40.47%	37.80%	39.32%	33.68%	30.81%	33.82%	33.10%	5.85%	37.74%	40.56%	35.86%	36.08%	19.80%	36.06%	33.31%	33.21%	22.41%	53.89%	15.88%	20.49%	23.85%	27.95%	33.12%	26.26%	29.33%	29.95%	21.25%	31.84%
Net Income	510.00M	581.00M	688.00M	807.00M	881.00M	1.03B	1.21B	1.30B	1.04B	1.46B	2.00B	1.85B	1.84B	1.81B	4.16B	3.10B	3.94B	4.48B	3.91B	4.69B	5.39B	5.22B	4.60B	5.53B	1.63B	5.26B	4.50B	5.44B	2.76B	8.42B	912.00M	1.53B	3.62B	4.64B	5.75B	4.38B	14.96B	4.93B	2.58B	5.72B
Net Income Margin	29.29%	28.22%	26.77%	25.39%	25.93%	25.22%	24.48%	22.97%	16.04%	13.90%	23.94%	23.18%	23.00%	21.33%	23.02%	15.10%	18.55%	20.91%	19.55%	21.65%	23.20%	22.95%	18.90%	19.50%	5.76%	19.21%	17.02%	20.51%	11.98%	35.20%	3.27%	5.08%	11.75%	13.76%	23.61%	17.76%	51.00%	16.25%	8.21%	17.50%
R&D	149.00M	230.00M	323.00M	420.00M	475.00M	595.00M	739.00M	858.00M	-	1.54B	1.16B	1.15B	1.16B	1.27B	2.53B	2.56B	2.90B	2.79B	2.90B	3.14B	3.46B	3.24B	3.68B	4.11B	4.46B	4.01B	3.98B	3.92B	3.45B	3.56B	3.63B	4.48B	3.89B	4.57B	4.79B	5.02B	5.49B	6.22B	6.40B	7.53B
R&D as % of Total Revenue	8.56%	11.17%	12.57%	13.21%	13.98%	14.53%	14.99%	15.17%	-	14.68%	13.92%	14.39%	14.57%	14.95%	13.97%	12.47%	13.67%	13.02%	14.53%	14.48%	14.89%	14.25%	15.12%	14.47%	15.70%	14.64%	15.05%	14.80%	15.00%	14.88%	13.01%	14.83%	12.63%	13.53%	19.68%	20.32%	18.72%	20.52%	20.40%	23.04%
Interest Expense	11.00M	21.00M	26.00M	44.00M	75.00M	63.00M	56.00M	44.00M	0	337.00M	276.00M	227.00M	202.00M	206.00M	317.00M	1.15B	206.00M	161.00M	362.00M	451.00M	352.00M	314.85M	843.00M	783.00M	765.36M	742.34M	734.97M	767.00M	696.20M	757.00M	736.00M	734.00M	743.64M	912.00M	892.00M	784.00M	855.53M	775.00M	657.58M	687.00M
Interest Expense % of Total Revenue	0.63%	1.02%	1.01%	1.38%	2.21%	1.54%	1.14%	0.78%	0.00%	3.21%	3.31%	2.84%	2.53%	2.43%	1.75%	5.59%	0.97%	0.75%	1.81%	2.08%	1.52%	1.38%	3.46%	2.76%	2.70%	2.71%	2.78%	2.89%	3.03%	3.16%	2.64%	2.43%	2.41%	2.70%	3.66%	3.17%	2.92%	2.56%	2.10%	2.10%

Balance Sheet

Currency: GBP	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.36B	2.87B	3.47B	4.49B	5.74B	5.68B	7.46B	7.89B	8.10B	8.54B	8.31B	8.44B	9.35B	10.43B	21.59B	21.97B	22.33B	23.94B	22.94B	27.20B	25.55B	31.00B	39.39B	42.86B	42.05B	41.08B	41.48B	42.09B	40.65B	53.45B	59.08B	56.38B	58.07B	105.57B	109.95B	107.14B	60.15B	75.22B	59.46B	61.12B
Total Liabilities	894.00M	1.06B	1.16B	1.69B	2.46B	2.04B	2.80B	2.74B	7.53B	8.32B	7.05B	6.55B	6.58B	7.23B	12.63B	13.57B	14.94B	15.49B	17.01B	19.63B	15.90B	21.09B	31.07B	32.12B	32.31B	32.25B	34.73B	34.27B	35.72B	44.57B	54.12B	52.89B	54.39B	81.25B	81.50B	78.23B	50.05B	58.91B	46.38B	45.16B
Total Equity	1.45B	1.78B	2.29B	2.73B	3.21B	3.57B	4.55B	5.03B	410.48M	91.00M	1.23B	1.84B	2.70B	3.14B	7.71B	7.53B	6.58B	7.71B	5.72B	7.31B	9.39B	9.60B	7.93B	10.01B	8.89B	8.03B	5.81B	7.00B	4.94B	8.88B	4.96B	3.49B	3.78B	15.11B	19.94B	20.39B	10.60B	17.01B	13.67B	16.38B
Cash	23.00M	40.00M	575.00M	266.00M	34.00M	24.00M	63.00M	55.00M	75.10M	233.00M	261.00M	215.00M	240.00M	217.00M	1.28B	717.82M	1.05B	960.96M	2.47B	4.21B	2.00B	3.38B	5.62B	6.54B	6.06B	5.71B	4.18B	5.53B	4.34B	5.83B	4.90B	3.83B	3.87B	6.24B	8.60B	5.79B	3.72B	3.74B	3.69B	3.40B
Total Debt	210.00M	264.00M	174.00M	469.00M	1.01B	503.00M	809.00M	672.00M	4.18B	4.47B	3.25B	3.02B	3.12B	3.51B	4.03B	4.24B	4.64B	5.10B	5.96B	7.36B	5.49B	10.57B	16.19B	16.26B	15.10B	14.90B	18.30B	18.25B	18.78B	16.63B	18.79B	17.09B	26.06B	40.42B	37.11B	32.74B	20.99B	22.97B	16.99B	17.69B
Net Debt	187.00M	224.00M	-401.00M	203.00M	977.00M	479.00M	746.00M	617.00M	4.10B	4.24B	2.98B	2.81B	2.88B	3.29B	2.75B	3.52B	3.59B	4.14B	3.50B	3.16B	3.48B	7.19B	10.56B	9.71B	9.04B	9.19B	14.12B	12.71B	14.45B	10.80B	13.89B	13.26B	22.19B	34.18B	28.51B	26.95B	17.26B	19.23B	13.29B	14.45B

Cash Flow

Currency: GBP	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	615.00M	657.00M	927.00M	1.05B	2.45B	1.25B	849.00M	615.00M	410.00M	510.00M	1.85B	4.61B	3.06B	4.85B	4.94B	6.20B	4.08B	6.17B	7.31B	7.84B	6.80B	6.25B	4.38B	7.22B	5.18B	2.57B	6.50B	6.92B	8.42B	8.02B	8.44B	7.95B	7.40B	7.89B	6.55B	7.74B
Investing Cash Flow	-851.00M	-372.00M	-858.00M	-1.36B	-4.74B	-4.79B	-104.00M	-657.00M	-830.00M	-896.00M	-484.00M	-2.44B	-1.12B	-954.00M	-919.68M	-2.07B	-1.76B	-3.01B	-2.07B	-4.01B	-1.87B	-112.00M	-2.63B	524.00M	-1.08B	6.04B	-1.27B	-1.44B	-1.55B	-5.35B	2.16B	-1.78B	-8.77B	-2.40B	-1.23B	-4.23B
Financing Cash Flow	473.00M	-466.00M	96.00M	39.00M	2.18B	3.66B	-658.00M	-59.00M	339.00M	350.00M	-546.00M	-2.78B	-2.15B	-872.00M	-3.41B	-3.08B	-4.19B	-1.74B	-3.44B	-2.77B	-5.57B	-6.23B	-3.35B	-6.27B	-5.38B	-7.10B	-6.39B	-6.38B	-6.39B	-1.84B	-10.13B	-7.59B	823.00M	-6.07B	-4.73B	-3.69B
Capital Expenditure	606.00M	594.00M	608.00M	575.00M	485.59M	684.00M	401.00M	415.00M	475.00M	597.00M	1.10B	1.12B	1.23B	1.06B	255.00M	1.18B	1.59B	2.14B	2.07B	1.87B	1.64B	1.33B	1.52B	1.70B	1.75B	1.90B	2.35B	2.20B	1.80B	2.16B	2.24B	2.93B	2.26B	1.63B	2.98B	1.35B
Free Cash Flow	9.00M	63.00M	319.00M	478.00M	1.96B	568.00M	448.00M	200.00M	-65.00M	-87.00M	749.00M	3.49B	1.83B	3.79B	4.51B	4.41B	2.37B	3.65B	5.24B	5.97B	5.16B	4.92B	2.85B	5.52B	3.42B	668.00M	4.14B	4.72B	6.63B	5.86B	6.20B	5.02B	5.14B	6.26B	3.57B	6.39B
Dividends Paid	-	-	-	844.08M	844.08M	-	-	-	-	-	3.03B	2.33B	2.33B	2.33B	2.48B	2.39B	2.60B	2.81B	3.01B	3.09B	3.21B	3.41B	3.81B	3.68B	3.84B	3.87B	4.85B	3.91B	3.93B	3.95B	3.98B	4.00B	3.47B	2.79B	2.44B	2.56B
FCF to OCF	1.46%	9.59%	34.41%	45.39%	80.17%	45.37%	52.77%	32.52%	-15.85%	-17.06%	40.44%	75.75%	59.90%	78.11%	91.30%	71.10%	58.06%	59.22%	71.70%	76.11%	75.95%	78.75%	65.26%	76.45%	66.17%	26.00%	63.80%	68.17%	78.67%	73.03%	73.47%	63.14%	69.50%	79.30%	54.50%	82.59%
Dividend Paid to FCF	-	-	-	176.59%	42.99%	-	-	-	-	-	404.92%	66.75%	126.95%	61.56%	54.85%	54.24%	109.71%	76.93%	57.38%	51.81%	62.09%	69.20%	133.59%	66.65%	112.20%	579.94%	117.01%	82.82%	59.28%	67.49%	64.12%	79.65%	67.39%	44.64%	68.42%	40.11%

Earnings

Report Date	Sep 14, 1993	Sep 8, 1994	Feb 7, 1995	Mar 6, 1996	Aug 5, 1996	Mar 7, 1997	Aug 4, 1997	Aug 12, 1998	Feb 18, 1999	Aug 2, 1999	Feb 16, 2000	Jun 30, 2000	Jul 27, 2000	Oct 31, 2000	Apr 23, 2001	Jul 24, 2001	Oct 23, 2001	Feb 14, 2002	Apr 25, 2002	Jul 24, 2002	Oct 23, 2002	Feb 12, 2003	Apr 30, 2003	Jul 23, 2003	Oct 22, 2003	Feb 12, 2004	Apr 29, 2004	Jul 27, 2004	Oct 28, 2004	Feb 10, 2005	Apr 28, 2005	Jul 27, 2005	Oct 27, 2005	Feb 8, 2006	Apr 27, 2006	Jul 26, 2006	Oct 26, 2006	Feb 8, 2007	Apr 25, 2007	Jul 25, 2007	Oct 24, 2007	Feb 7, 2008	Apr 23, 2008	Jul 23, 2008	Oct 22, 2008	Feb 5, 2009	Apr 22, 2009	Jul 22, 2009	Oct 28, 2009	Feb 4, 2010	Apr 28, 2010	Jul 21, 2010	Oct 21, 2010	Feb 3, 2011	Apr 27, 2011	Jul 26, 2011	Oct 26, 2011	Feb 7, 2012	Apr 25, 2012	Jul 25, 2012	Oct 31, 2012	Feb 6, 2013	Apr 24, 2013	Jul 24, 2013	Oct 23, 2013	Feb 5, 2014	Apr 30, 2014	Jul 23, 2014	Oct 22, 2014	Feb 4, 2015	May 6, 2015	Jul 29, 2015	Oct 28, 2015	Feb 3, 2016	Apr 27, 2016	Jul 27, 2016	Oct 26, 2016	Feb 8, 2017	Apr 26, 2017	Jul 26, 2017	Oct 25, 2017	Feb 7, 2018	Apr 25, 2018	Jul 25, 2018	Oct 31, 2018	Feb 6, 2019	May 1, 2019	Jul 24, 2019	Oct 30, 2019	Feb 5, 2020	Apr 29, 2020	Jul 29, 2020	Oct 28, 2020	Feb 3, 2021	Apr 28, 2021	Jul 28, 2021	Oct 27, 2021	Feb 9, 2022	Apr 27, 2022	Jul 27, 2022	Nov 2, 2022	Feb 1, 2023	Apr 26, 2023	Jul 26, 2023	Nov 1, 2023	Jan 31, 2024	May 1, 2024	Jul 31, 2024	Oct 30, 2024	Feb 5, 2025	Apr 30, 2025	Jul 30, 2025	Oct 29, 2025	Feb 4, 2026	Apr 29, 2026	Jul 28, 2026	Oct 28, 2026	Nov 4, 2026
EPS Estimate	0.82	0.81	0.90	1.02	1.05	1.13	1.19	0.99	1.06	1.05	1.13	0.89	1.11	1.16	1.16	0.70	0.56	0.71	0.67	0.81	0.55	0.83	0.74	0.86	0.78	0.79	0.88	0.88	0.83	0.84	1.04	0.96	0.89	0.82	1.01	1.06	1.05	1.05	1.31	1.14	1.19	1.09	-	1.24	1.19	-	-	-	1.23	-	0.74	0.56	1.25	1.33	1.11	0.77	0.92	0.97	1.14	1.08	1.15	1.31	0.99	1.00	1.04	1.24	-	0.88	0.99	1.08	-	-	0.76	0.64	0.64	0.69	0.93	0.78	0.77	0.84	1.02	0.84	0.86	0.97	1.07	0.88	0.80	0.78	1.00	0.76	0.78	0.71	1.07	0.60	0.60	0.41	1.02	0.81	0.96	0.73	0.89	0.55	0.82	0.87	1.14	0.77	0.94	0.98	1.16	0.49	1.04	1.11	1.26	0.62	1.16	1.27	1.40	1.45
EPS Actual	0.88	0.74	0.99	1.06	1.11	1.06	1.20	0.96	1.16	1.04	1.02	0.52	1.20	0.71	0.19	0.73	0.57	0.74	0.68	0.82	0.65	0.81	0.87	0.92	0.88	0.74	0.86	0.92	0.86	0.81	1.00	0.88	0.94	0.85	1.18	1.06	1.15	1.00	1.34	1.23	1.20	1.17	1.20	1.35	1.02	0.75	0.80	1.11	1.16	1.30	1.15	1.11	1.10	-0.30	1.32	1.01	1.10	1.11	1.06	1.02	1.05	1.26	1.03	1.01	1.15	1.21	0.57	0.81	1.12	1.04	5.03	0.09	0.88	0.65	0.72	0.80	0.98	0.82	0.80	0.89	1.08	0.94	0.86	0.92	1.13	1.01	0.98	0.95	1.24	0.81	1.16	0.62	1.16	0.80	0.80	0.98	1.26	0.87	1.03	0.87	1.07	0.64	0.92	1.00	1.22	0.73	1.08	1.11	1.29	0.58	1.20	1.24	1.46	0.70	1.26	1.36	1.47	-
Surprise	7.32%	-8.64%	10.00%	3.92%	5.71%	-6.19%	0.84%	-3.03%	9.43%	-0.95%	-9.73%	-41.57%	8.11%	-38.79%	-83.62%	4.29%	1.79%	4.23%	1.49%	1.23%	18.18%	-2.41%	17.57%	6.98%	12.82%	-6.33%	-2.27%	4.55%	3.61%	-3.57%	-3.85%	-8.33%	5.62%	3.66%	16.83%	0.00%	9.52%	-4.76%	2.29%	7.89%	0.84%	7.34%	-	8.87%	-14.29%	-	-	-	-5.69%	-	55.41%	98.21%	-12.00%	-122.56%	18.92%	31.17%	19.57%	14.43%	-7.02%	-5.56%	-8.70%	-3.82%	4.04%	1.00%	10.58%	-2.42%	-	-7.95%	13.13%	-3.70%	-	-	15.79%	1.56%	12.50%	15.94%	5.38%	5.13%	3.90%	5.95%	5.88%	11.90%	0.00%	-5.15%	5.61%	14.77%	22.50%	21.79%	24.00%	6.58%	48.72%	-12.68%	8.41%	33.33%	33.33%	139.02%	23.53%	7.41%	7.29%	19.18%	20.22%	16.36%	12.20%	14.94%	7.02%	-5.19%	14.89%	13.27%	11.21%	18.37%	15.38%	11.71%	15.87%	12.90%	8.62%	7.09%	5.00%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	Pre-market	-	Pre-market	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-	-	-	Pre-market	-	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap100.88B

Enterprise Value129.85B

Trailing P/E17.54

Forward P/E9.85

PEG Ratio6.35

Price / Sales3.01

Price / Book3.99

EPS2.87

Book Value12.53

Revenue (TTM)33.54B

Gross Profit (TTM)24.75B

EBITDA11.08B

Profit Margin12.97%

Operating Margin32.14%

Return on Equity28.27%

Return on Assets9.24%

Shares Outstanding2.00B

Shares Float1.94B

Beta0.28

Dividend Yield3.61%

Dividend Rate1.82

Payout Ratio38.48%

Analyst Ratings

Hold

Based on 9 analystsTarget 59.12

Strong Buy
2
Buy
1
Hold
5
Strong Sell
1

Ownership Breakdown

Institutions: 17.46%
Insiders: 0.08%
Retail / Other: 82.46%

Top Institutional Holders

FMR Inc
64.96M3.24%
Dodge & Cox
48.20M2.40%
Fisher Asset Management, LLC
35.72M1.78%
PRIMECAP Management Company
25.18M1.26%
Wellington Management Company LLP
11.40M0.57%
JTC Employer Solutions Trustee Ltd
8.59M0.43%
Morgan Stanley - Brokerage Accounts
7.66M0.38%
Royal Bank of Canada
7.59M0.38%
T. Rowe Price Associates, Inc.
6.92M0.35%
Acadian Asset Management LLC
6.66M0.33%
The Goldman Sachs Group Inc
6.37M0.32%
State Street Corp
5.96M0.30%
Mondrian Investment Partners Ltd
4.91M0.24%
Bank of Montreal
4.04M0.20%
BMO Capital Markets Corp.
4.04M0.20%

Top Fund Holders

Dodge & Cox Stock I
30.28M1.51%
Vanguard PRIMECAP Inv
18.21M0.91%
Vanguard Wellington Inv
8.64M0.43%
Strategic Advisers Fidelity US TtlStk
8.05M0.40%
Fidelity Series Large Cap Stock
4.58M0.23%

Dividends

20264×

0.44Nov 13, 20260.45Aug 14, 20260.46May 15, 20260.49Feb 20, 2026

20254×

0.42Nov 14, 20250.43Aug 15, 20250.43May 16, 20250.40Feb 21, 2025

20244×

0.39Nov 15, 20240.39Aug 16, 20240.38May 16, 20240.41Feb 22, 2024

20234×

0.34Nov 16, 20230.36Aug 17, 20230.35May 18, 20230.34Feb 23, 2023

20224×

0.32Nov 17, 20220.39Aug 18, 20220.35May 19, 20220.62Feb 24, 2022

20214×

0.52Nov 18, 20210.53Aug 19, 20210.53May 20, 20210.63Feb 18, 2021

Stock Splits

Jul 22, 20221226:1000
Nov 12, 19912:1
Jan 27, 19862:1
Feb 23, 19832:1